Cigarette smoking and risk of prostate cancer among Singapore Chinese

Cancer Causes and Control

Volumn 20, Issue 10, 2009, Pages 1967-1974

  Butler, Lesley M ^a   Wang, Renwei ^b   Wong, Alvin S ^c   Koh, Woon Puay ^d   Yu, Mimi C ^b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cigarette smoking; Epidemiology; Prospective study; Prostate cancer; Singapore Chinese

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CHINESE; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR; SINGAPORE; SMOKING CESSATION;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CARCINOMA; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK FACTORS; SINGAPORE; SMOKING; SOCIOECONOMIC FACTORS;

EID: 71349087446     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-009-9391-2     Document Type: Article

References (54)

1. TT Chen C Heidelberger 1969 Quantitative studies on the malignant transformation of mouse prostate cells by carcinogenic hydrocarbons in vitro Int J Cancer 4 2 166 178 10.1002/ijc.2910040207 1:CAS:528:DyaF1MXosFKrsA%3D%3D 4899788
2. JB Guttenplan M Chen W Kosinska S Thompson Z Zhao LA Cohen 2001 Effects of a lycopene-rich diet on spontaneous and benzo[a]pyrene-induced mutagenesis in prostate, colon and lungs of the lacZ mouse Cancer Lett 164 1 1 6 10.1016/S0304-3835(00)00705-9 1:CAS:528:DC%2BD3MXpsFCmsw%3D%3D 11166909 (Pubitemid 32144983)
3. SS Hecht 2003 Tobacco carcinogens, their biomarkers and tobacco-induced cancer Nat Rev 3 10 733 744 1:CAS:528:DC%2BD3sXotFCiu7s%3D
4. N Finnstrom C Bjelfman TG Soderstrom, et al.. 2001 Detection of cytochrome P450 mRNA transcripts in prostate samples by RT-PCR Eur J Clin Invest 31 10 880 886 10.1046/j.1365-2362.2001.00893.x 1:CAS:528:DC%2BD3MXot1Oqurw%3D 11737226 (Pubitemid 34592088)
5. GI Murray VE Taylor JA McKay, et al.. 1995 The immunohistochemical localization of drug-metabolizing enzymes in prostate cancer J Pathol 177 2 147 152 10.1002/path.1711770208 1:CAS:528:DyaK2MXpvF2htLk%3D 7490681
6. M Nishimura S Naito 2006 Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes Drug Metab Pharmacokinet 21 5 357 374 10.2133/dmpk.21.357 1:CAS:528:DC%2BD28XhtlWnsr7P 17072089
7. BA Rybicki A Rundle AT Savera SS Sankey D Tang 2004 Polycyclic aromatic hydrocarbon-DNA adducts in prostate cancer Cancer Res 64 24 8854 8859 10.1158/0008-5472.CAN-04-2323 1:CAS:528:DC%2BD2cXhtVOmsL%2FO 15604244 (Pubitemid 39665489)
8. G Scherer S Frank K Riedel I Meger-Kossien T Renner 2000 Biomonitoring of exposure to polycyclic aromatic hydrocarbons of nonoccupationally exposed persons Cancer Epidemiol Biomarkers Prev 9 4 373 380 1:CAS:528: DC%2BD3cXjt1Cks74%3D 10794481
9. K Hickey KA Do A Green 2001 Smoking and prostate cancer Epidemiol Rev 23 1 115 125 1:STN:280:DC%2BD3Mrkt1SlsQ%3D%3D 11588835
10. E Giovannucci EB Rimm A Ascherio, et al.. 1999 Smoking and risk of total and fatal prostate cancer in United States health professionals Cancer Epidemiol Biomarkers Prev 8 4 Pt 277 282 1:STN:280:DyaK1M3isVSgtw%3D%3D 10207628
11. Z Gong I Agalliu DW Lin JL Stanford AR Kristal 2008 Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men Cancer Causes Control 19 1 25 31 10.1007/s10552-007-9066-9 17906959
12. AW Hsing JK McLaughlin LM Schuman, et al.. 1990 Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort study Cancer Res 50 21 6836 6840 1:STN:280:DyaK3M%2FgsVSnuw%3D%3D 2208150
13. C Rodriguez LM Tatham MJ Thun EE Calle CW Heath Jr 1997 Smoking and fatal prostate cancer in a large cohort of adult men Am J Epidemiol 145 5 466 475 1:STN:280:DyaK2s3gtVKqsA%3D%3D 9048521 (Pubitemid 27084219)
14. SS Coughlin JD Neaton A Sengupta 1996 Cigarette smoking as a predictor of death from prostate cancer in 348, 874 men screened for the multiple risk factor intervention trial Am J Epidemiol 143 10 1002 1006 1:STN:280: DyaK283ht1Oluw%3D%3D 8629606
15. F Jin SS Devesa WH Chow, et al.. 1999 Cancer incidence trends in urban shanghai, 1972-1994: an update Int J Cancer 83 4 435 440 10.1002/(SICI)1097- 0215(19991112)83:4<435::AID-IJC1>3.0.CO;2-J 1:STN:280:DyaK1MvjvVWhsw%3D%3D 10508476 (Pubitemid 29489855)
16. US Cancer Statistics Working Group (2007) United States Cancer Statistics: 1999-2004 Incidence and Mortality Web-based Report. Atlanta, US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, available at www.cdc.gov/uscs
17. Seow A, Koh WP, Chia KS, Shi LM, Lee HP, Shanmugaratnam K (2004) Trends in cancer incidence in Singapore 1968-2002: Singapore Cancer Registry, Report No. 6
18. HG Sim CW Cheng 2005 Changing demography of prostate cancer in Asia Eur J Cancer 41 6 834 845 10.1016/j.ejca.2004.12.033 15808953 (Pubitemid 40467547)
19. I Cheng MC Yu WP Koh, et al.. 2005 Comparison of prostate-specific antigen and hormone levels among men in Singapore and the United States Cancer Epidemiol Biomarkers Prev 14 7 1692 1696 10.1158/1055-9965.EPI-04-0864 1:CAS:528:DC%2BD2MXmt1Grsb0%3D 16030103 (Pubitemid 40995081)
20. Singapore Urological Association (2004) Guidelines: the management of prostatic cancer. http://www.sua.org.sg/guidelines/whatsnew-mprostatic.htm. Accessed 13 Oct 2008
21. SJ Jacobsen SK Katusic EJ Bergstralh, et al.. 1995 Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing Jama 274 18 1445 1449 10.1001/jama.274.18.1445 1:STN:280: DyaK28%2FlsFShsQ%3D%3D 7474190
22. AL Potosky BA Miller PC Albertsen BS Kramer 1995 The role of increasing detection in the rising incidence of prostate cancer JAMA 273 7 548 552 10.1001/jama.273.7.548 1:STN:280:DyaK2M7jvFWqtA%3D%3D 7530782
23. R Etzioni KM Berry JM Legler P Shaw 2002 Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998 Urology 59 2 251 255 10.1016/S0090-4295(01)01516-3 11834397 (Pubitemid 34134526)
24. SL Yao G Lu-Yao 2002 Understanding and appreciating overdiagnosis in the PSA era J Natl Cancer Inst 94 13 958 960 12096074
25. S Loeb CM Gonzalez KA Roehl, et al.. 2006 Pathological characteristics of prostate cancer detected through prostate specific antigen based screening J Urol 175 3 Pt 1 902 906 10.1016/S0022-5347(05)00327-7 16469576 (Pubitemid 43200014)
26. JI Epstein PC Walsh M Carmichael CB Brendler 1994 Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer Jama 271 5 368 374 10.1001/jama.271.5.368 1:STN:280:DyaK2c7htFalsA%3D%3D 7506797 (Pubitemid 24037911)
27. JM Yuan DO Stram K Arakawa HP Lee MC Yu 2003 Dietary cryptoxanthin and reduced risk of lung cancer: the Singapore Chinese health study Cancer Epidemiol Biomarkers Prev 12 9 890 898 1:CAS:528:DC%2BD3sXnsValt70%3D 14504200
28. Parkin DM, Whelan SL, Ferlay J, Teppo L, De Thomas (2003) Cancer incidence in five continents. International Agency for Research on Cancer, Lyon
29. Greene F, Page D, Fleming I, et al. (2002) AJCC cancer staging manual, 6th edn. Lippincott-Raven, Philadelphia
30. AV D'Amico R Whittington SB Malkowicz, et al.. 1998 Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 11 969 974 10.1001/jama.280.11.969 9749478 (Pubitemid 28445094)
31. JH Hankin DO Stram K Arakawa, et al.. 2001 Singapore Chinese health study: development, validation, and calibration of the quantitative food frequency questionnaire Nutr Cancer 39 2 187 195 10.1207/S15327914nc392-5 1:CAS:528:DC%2BD3MXpt1Wht7w%3D 11759279
32. D Cox 1972 Regression models and life tables J Roy Stat Soc B 18 7 220
33. Lee HP, Ling A, Yew KC, et al. (2007) Trends in cancer incidence in Singapore 2001-2005, Singapore Cancer Registry, Interim Report
34. A Shankar JM Yuan WP Koh HP Lee MC Yu 2008 Morbidity and mortality in relation to smoking among women and men of Chinese ethnicity: the Singapore Chinese health study Eur J Cancer 44 1 100 109 10.1016/j.ejca.2007.10.015 18006298 (Pubitemid 350256946)
35. J Dallongeville N Marecaux JC Fruchart P Amouyel 1998 Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis J Nutr 128 9 1450 1457 1:CAS:528:DyaK1cXlvVWjsbo%3D 9732304
36. K Marangon B Herbeth E Lecomte, et al.. 1998 Diet, antioxidant status, and smoking habits in French men Am J Clin Nutr 67 2 231 239 1:CAS:528:DyaK1cXntVegtA%3D%3D 9459370
37. AF Subar LC Harlan ME Mattson 1990 Food and nutrient intake differences between smokers and non-smokers in the US Am J Public Health 80 11 1323 1329 10.2105/AJPH.80.11.1323 1:STN:280:DyaK3M%2Flt1Siug%3D%3D 2240298
38. WP Koh JM Yuan CL Sun HP Lee MC Yu 2005 Middle-aged and older Chinese men and women in Singapore who smoke have less healthy diets and lifestyles than nonsmokers J Nutr 135 10 2473 2477 1:CAS:528:DC%2BD2MXhtFWjur%2FJ 16177215
39. E Giovannucci Y Liu EA Platz MJ Stampfer WC Willett 2007 Risk factors for prostate cancer incidence and progression in the health professionals follow-up study Int J Cancer 121 7 1571 1578 10.1002/ijc.22788 1:CAS:528: DC%2BD2sXhtVSns7zO 17450530 (Pubitemid 47328718)
40. JJ Michnovicz RJ Hershcopf H Naganuma HL Bradlow J Fishman 1986 Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking N Engl J Med 315 21 1305 1309 1:CAS:528: DyaL2sXhsVGitw%3D%3D 3773953
41. B MacMahon D Trichopoulos P Cole J Brown 1982 Cigarette smoking and urinary estrogens N Engl J Med 307 17 1062 1065 1:CAS:528:DyaL38XlvFCnsLk%3D 7121516
42. MA Moyad 2002 Is obesity a risk factor for prostate cancer, and does it even matter? A hypothesis and different perspective Urology 59 4 Suppl 1 41 50 10.1016/S0090-4295(01)01175-X 11937435 (Pubitemid 34286430)
43. E Barrett-Connor KT Khaw 1987 Cigarette smoking and increased endogenous estrogen levels in men Am J Epidemiol 126 2 187 192 1:STN:280: DyaL2s3mslGhsA%3D%3D 3605047
44. E Giovannucci EB Rimm MJ Stampfer GA Colditz WC Willett 1997 Height, body weight, and risk of prostate cancer Cancer Epidemiol Biomarkers Prev 6 8 557 563 1:STN:280:DyaK2svgslGiug%3D%3D 9264267
45. EP Diamandis H Yu 1996 Does prostate cancer start at puberty? J Clin Lab Anal 10 6 468 469 10.1002/(SICI)1098-2825(1996)10:6<468::AID-JCLA27>3.0. CO;2-U 1:STN:280:DyaK2s7gvFensA%3D%3D 8951622 (Pubitemid 26398942)
46. RK Ross BE Henderson 1994 Do diet and androgens alter prostate cancer risk via a common etiologic pathway? J Natl Cancer Inst 86 4 252 254 10.1093/jnci/86.4.252 1:STN:280:DyaK2c3htVGhsQ%3D%3D 8158675
47. GS Prins O Putz 2008 Molecular signaling pathways that regulate prostate gland development Differentiation 76 6 641 659 10.1111/j.1432-0436.2008.00277.x 1:CAS:528:DC%2BD1cXhtVSrsLfO 18462433 (Pubitemid 352032742)
48. GS Prins 2008 Endocrine disruptors and prostate cancer risk Endocr Relat Cancer 15 3 649 656 10.1677/ERC-08-0043 1:CAS:528:DC%2BD1cXhtlWit7bL 18524946
49. TL Smith ST Merry DL Harris, et al.. 2007 Species-specific testicular and hepatic microsomal metabolism of benzo(a)pyrene, an ubiquitous toxicant and endocrine disruptor Toxicol In Vitro 21 4 753 758 10.1016/j.tiv.2007.01.005 1:CAS:528:DC%2BD2sXkt1aktb8%3D 17317092 (Pubitemid 46550756)
50. AE Archibong A Ramesh MS Niaz CM Brooks SI Roberson DD Lunstra 2008 Effects of benzo(a)pyrene on intra-testicular function in F-344 rats Int J Environ Res Public Health 5 1 32 40 10.3390/ijerph5010032 1:CAS:528: DC%2BD1cXnvVaks74%3D 18441403
51. SO Andersson J Baron A Wolk C Lindgren R Bergstrom HO Adami 1995 Early life risk factors for prostate cancer: a population-based case-control study in Sweden Cancer Epidemiol Biomarkers Prev 4 3 187 192 1:STN:280: DyaK2MzivF2lug%3D%3D 7606192
52. M Lodde F Harel L Lacombe Y Fradet 2008 Substratification of high-risk localised prostate cancer treated by radical prostatectomy World J Urol 26 3 225 229 10.1007/s00345-008-0252-5 18369635
53. SA Boorjian RJ Karnes LJ Rangel EJ Bergstralh ML Blute 2008 Mayo clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy J Urol 179 (4 1354 1360 10.1016/j.juro.2007.11. 061 18289596 discussion 1360-1351
54. NL Nock X Liu MS Cicek, et al.. 2006 Polymorphisms in polycyclic aromatic hydrocarbon metabolism and conjugation genes, interactions with smoking and prostate cancer risk Cancer Epidemiol Biomarkers Prev 15 4 756 761 10.1158/1055-9965.EPI-05-0826 1:CAS:528:DC%2BD28XjsVWrtLg%3D 16614120